tm logo
LASER PAD
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 22 Apr 2023

Last Applicant/ Owned by

6521 Davis Industrial Pkwy

Solon

OH

44139

Serial Number

86671792 filed on 23rd Jun 2015

Registration Number

5120357 registered on 10th Jan 2017

in the Principal Register

Correspondent Address

MARK E. BANDY

Rankin Hill & Clark Llp

38210 Glenn Ave

Willoughby OH 44094-7808

Filing Basis

1. intent to use

2. use application currently

Disclaimer

"LASER"

LASER PAD

Light-based medical devices, namely, devices using low level lasers, light-emitting diodes, infrared light and pulsed light for treating diseases and providing therapeutic applications namely, muscle, skeletal, nerve and skin therapies "LASER"

Classification Information


Class [010]
Medical Instrument Products


Light-based medical devices, namely, devices using low level lasers, light-emitting diodes, infrared light and pulsed light for treating diseases and providing therapeutic applications namely, muscle, skeletal, nerve and skin therapies


First Use Date in General

01st Dec 2012

First Use Date in Commerce

01st Dec 2012

Specimens


LASER PAD specimenLASER PAD specimenLASER PAD specimen

Mark Details


Serial Number

No 86671792

Mark Type

No Service/Collective Mark

Attorney Docket Number

No MQU-39706

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
22nd Apr 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
22nd Apr 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
22nd Apr 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13th Oct 2022TEAS SECTION 8 & 15 RECEIVED
10th Jan 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10th Jan 2017REGISTERED-PRINCIPAL REGISTER
03rd Dec 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02th Dec 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02th Dec 2016EXAMINER'S AMENDMENT ENTERED
02th Dec 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED